The immune system can affect learning: Chronic immune complex disease in a rat model

Journal of Neuroimmunology

Volumn 86, Issue 2, 1998, Pages 163-170

  Hoffman, Steven A ^a   Shucard, David Wm ^b   Harbeck, Ronald J ^c  

^a ARIZONA STATE UNIVERSITY   (United States)

^b UNIVERSITY AT BUFFALO   (United States)

^c NATIONAL JEWISH MEDICAL AND RESEARCH CENTER   (United States)

Author keywords

Behavior; Immune complex disease; Memory and learning; Neuro immune interactions; Systemic lupus erythematosus

Indexed keywords

ANIMAL MODEL; ARTICLE; IMMUNE COMPLEX DISEASE; IMMUNE SYSTEM; LEARNING; MALE; MEMORY; NEUROIMMUNOLOGY; NONHUMAN; PRIORITY JOURNAL; RAT; SYSTEMIC LUPUS ERYTHEMATOSUS;

ANIMALS; BEHAVIOR, ANIMAL; CHOROID PLEXUS; CHRONIC DISEASE; COGNITION; DISEASE MODELS, ANIMAL; IMMUNE COMPLEX DISEASES; IMMUNE SYSTEM; KIDNEY GLOMERULUS; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; MAZE LEARNING; MEMORY; MOTOR ACTIVITY; NEUROIMMUNOMODULATION; PROTEINURIA; RATS; RATS, SPRAGUE-DAWLEY;

EID: 0032525826     PISSN: 01655728     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-5728(98)00052-6     Document Type: Article

References (57)

1. Atkins C.J., Kondon J.J., Quismorio F.P., Friou G.J. The choroid plexus in systemic lupus erythematosus. Ann. Int. Med. 76:1972;65-72.
2. Bartholomew S.A., Hoffman S.A. Effects of peripheral cytokine injections on multiple unit activity in the anterior hypothalamic area of the mouse. Brain Behav. Immunol. 7:1993;301-316.
3. Bluestein H.G., Williams G.W., Steinberg A.D. Cerebrospinal fluid antibodies to neuronal cells: association with neuropsychiatric manifestations of systemic lupus erythematosus. Am. J. Med. 70:1981;240-246.
4. Crestani F., Seguy F., Dantzer R. Behavioural effects of peripherally injected interleukin-1: role of prostaglandins. Brain Res. 542:1991;330-335.
5. Crimando, J., Cooper, K., Hoffman, S.A., 1997. Inhibition of inward sodium channel currents by antineuronal autoantibody from autoimmune mice. In: Moore, P. (Ed.), Neuropsychiatric Manifestations of Systemic Lupus Erythematosus. New York Academy of Sciences, New York.
6. Dafny N., Lee J.R., Dougherty P.M. Immune response products alter CNS activity: interferon modulates central opioid functions. J. Neurosci. Res. 19:1988;130-139.
7. Denburg J.A., Denburg S.D., Carbotte R.M., Long A.A., Hanly J.G. Nervous system involvement in systemic lupus erythematosus. Isr. J. Med. Sci. 24:1988;754-758.
8. Denburg S.D., Denburg J.A., Carbotte R.M., Fisk J.D., Hanly J.G. Cognitive deficits in systemic lupus erythematosus. Rheum. Dis. Clin. N. Am. 19:1993;815-831.
9. Denburg S.D., Behmann S.A., Carbotte R.M., Denburg J.A. Lymphocyte antigens in neuropsychiatric systemic lupus erythematosus - relationship of lymphocyte antibody specificities to clinical disease. Arthritis Rheum. 37:1994;369-375.
10. Denburg S.D., Carbotte R.M., Denburg J.A. Corticosteroids and neuropsychological functioning in patients with systemic lupus erythematosus. Arthritis Rheum. 37:1994;1311-1320.
11. Denburg S.D., Carbotte R.M., Denburg J.A. Psychological aspects of systemic lupus erythematosus: Cognitive function, mood and self-report. J. Rheumatol. 24:1997;998-1003.
12. Forster M.J., Lal H. Animal models of age-related dementia - neurobehavioral dysfunctions in autoimmune mice. Br. Res. Bull. 25:1990;503-516.
13. Fukata J., Imura H., Nakao K. Cytokines as mediators in the regulation of the hypothalamic-pituitary-adrenocortical function. J. Endocrinol. Invest. 16:1993;141-155.
14. Gershwin M.E., Hyman L.R.H., Steinberg A.D. The choroid plexus in CNS involvement of systemic lupus erythematosus. J. Ped. 87:1975;588-590.
15. Gustafson J.W. Distractibility and reactivity under different response conditions following hippocampal lesions in rats. Behav. Biol. 15:1975;479-484.
16. Hanly J.G., Walsh N.M., Fisk J.D., Eastwood B., Hong C., Sherwood G., Jones J.V., Jones E., Elkon K. Cognitive impairment and autoantibodies in systemic lupus erythematosus. Br. J. Rheumatol. 32:1993;291-296.
17. Harbeck R.J., Hoffman A.A., Hoffman S.A., Shucard D.W. Cerebrospinal fluid and the choroid plexus during acute immune complex disease. Clin. Immunol. Immunopathol. 13:1979;413-425.
18. Harley C.W. Nonreversal and reversal shifts in the hippocampectomized rat. Phys. Behav. 22:1979;1135-1139.
19. Harris E.N., Hughes G.R.V. Cerebral disease in systemic lupus erythematosus. Springer Sem. Immunopathol. 8:1985;251-266.
20. Hirohata S., Miyamoto T. Elevated levels of interleukin-6 in cerebrospinal fluid from patients with systemic lupus erythematosus and central nervous system involvement. Arthritis Rheum. 33:1990;644-649.
21. Hoffman S.A., Arbogast D.N., Day T.T., Shucard D.W., Harbeck R.J. Permeability of the blood cerebrospinal fluid barrier during acute immune complex disease. J. Immunol. 130:1983;1695-1698.
22. Hoffman, S.A., Harbeck, R.J., 1989. CNS lupus and the blood-brain barrier. In: Neuwelt, E.A. (Ed.), Implications of the Blood-Brain Barrier and Its Manipulation Volume 2 Clinical Aspects. Plenum Medical, New York, pp. 469-494.
23. Hoffman S.A., Narendran A., Shucard D.W., Harbeck R.J. Autoantibodies, immune complexes, and behavioral disorders: Neuropsychiatric involvement in systemic lupus erythematosus. Drug Dev. Res. 15:1988;237-251.
24. Hoffman S.A., Shucard D.W., Harbeck R.J., Hoffman A.A. Chronic immune complex disease: behavioral and immunological correlates. J. Neuropathol. Exp. Neurol. 37:1978;426-436.
25. Johnson R.T., Richardson E.P. The neurological manifestations of systemic lupus erythematosus: a clinical-pathological study of 24 cases and review of the literature. Medicine. 47:1968;337-369.
26. Katafuchi T., Hori T., Take S. Central administration of interferon-alpha enhances rat sympathetic nerve activity to the spleen. Neurosci. Lett. 125:1991;37-40.
27. Kracke, R.R., Parker, F.P., 1940. Textbook of Clinical Pathology. Williams and Wilkins.
28. Lapchak P.A. A role for interleukin-2 in the regulation of striatal dopaminergic function. Neuroreport. 3:1992;165-168.
29. Lashley, K.S., 1929. Brain Mechanisms and Intelligence: A Quantitative Study of Injuries to the Brain. University of Chicago Press, Chicago.
30. Lutomski D., Caron M., Bourin P., Lefebure C., Bladier D., Joubert-Caron R. Purification and characterization of natural antibodies that recognize a human brain lectin. J. Neuroimmunol. 57:1995;9-15.
31. Maes M., Bosmans E., Suy E., Vandervorst C., Dejonckheere C., Raus J. Immune disturbances during major depression: upregulated expression of interleukin-2 receptors. Neuropsychobiology. 24:1990;115-120.
32. McCune W.J., Golbus J. Neuropsychiatric lupus. Rheum. Dis. Clin. N. Am. 14:1988;149-167.
33. Miller D.J., Rodriquez M. A monoclonal autoantibody that promotes central nervous system remyelination in a model of multiple sclerosis is a natural autoantibody encoded by germline immunoglobulin genes. J. Immunol. 154:1995;2460-2469.
34. Packard M.G., Hirsh R., White N.M. Differential effects of fornix and caudate nucleus lesions on two radial maze tasks: evidence for multiple memory systems. J. Neurosci. 9:1989;1465-1472.
35. Peress N.S., Tompkins D.C Rat CNS in experimental chronic serum sickness: Integrity of the zonulae occludentes of the choroid plexus epithelium and brain endothelium in experimental chronic serum sickness. Neuropathol. Appl. Neurobiol. 5:1979;279-288.
36. Peress N.S., Miller F., Palu W. The immunopathophysiological effects of chronic serum sickness on rat choroid plexus, ciliary process and renal glomeruli. J. Neuropathol. Exp. Neurol. 36:1977;726-733.
37. Peress N.S., Miller F., Palu W. The choroid plexus in passive serum sickness. J. Neuropathol. Exp. Neurol. 36:1977;561-566.
38. Sakic B., Szechtman H., Denburg S., Carbotte R., Denburg J.A. Brain-reactive antibodies and behavior of autoimmune MRL-1pr mice. Physiol. Behav. 54:1993;1025-1029.
39. Schiffer, R.B., Hoffman, S.A., 1991. Behavioral sequlae of autoimmune disease. In: Ader, R., Felten, D., Cohen, N. (Eds.), Psychoneuroimmunology. Academic Press, New York, pp. 1037-1066.
40. Schrott L.M., Crnic L.S. Sensitivity to foot shock in autoimmune NZB×NZW F1 hybrid mice. Physiol. Behav. 56:1994;849-853.
41. Schupf N., Williams C.A. Effect of immune complex-forming reactants on catecholamine-modulated behaviors in the rat hypothalamus. J. Neuroimmunol. 9:1985;13-27.
42. Schupf N., Williams C.A., Hugli T.E., Cox J. Psychopharmacological activity of anaphylatoxin C3a in rat hypothalamus. J. Neuroimmunol. 5:1983;305-316.
43. Sher J.H., Pertschuk L.P. Immunoglobulin G deposits in the choroid plexus of a child with systemic lupus erythematosus. J. Ped. 85:1974;385-387.
44. Shintani F., Kanba S., Nakaki T., Nibuya M., Kinoshita N., Suzuki E., Yagi G., Kato R., Asai M. Interleukin-1B augments release of norepinephrine, dopamine and serotonin in the rat anterior hypothalamus. J. Neurosci. 13:1993;3574-3581.
45. Shiozawa S., Kurcki Y., Kim M., Hirohata S., Ogino T. Interferon-alpha in lupus psychosis. Arthritis Rheum. 35:1992;417-422.
46. Tehrani M.J., Hu Y., Marquette C., Dietrich H., Haour F., Wick G. Interleukin-1 receptor deficiency in brains from NZB and (NZB/NZW)F1 autoimmune mice. J. Neuroimmunol. 53:1994;91-99.
47. van Dam A.P. Diagnosis and pathogenesis of CNS lupus. Rheumatology. 11:1991;1-11.
48. Vogelweid C.M., Wright D.C., Johnson J.C., Hewett J.E., Walker S.E. Evaluation of memory, learning ability and clinical neurologic function in pathogen-free mice with systemic lupus erythematosus. Arthritis Rheum. 37:1994;889-897.
49. Weir, D.M., Herzenberg, L.A., Blackwell, C., Herzenberg, L.A., 1986. Handbook of Experimental Immunology. Blackwell, Oxford.
50. West S.G., Emlen W., Wener M.H., Kotzin B.L. Neuropsychiatric lupus erythematosus: a 10-yr prospective study on the value of diagnostic tests. Am. J. Med. 99:1995;153-163.
51. Wickelgren W.O., Isaacson R.L. Effect of the introduction of an irrelevant stimulus on runway performance of the hippocampectomized rat. Nature. 200:1963;48-50.
52. Williams C.A., Schupf N., Hugli T.E. Anaphylatoxin C5a modulation of an alpha-adrenergic receptor system in the rat hypothalamus. J. Neuroimmunol. 9:1985;29-40.
53. Xavier G.F., Stein C., Bueno O.F.A. Rats with dorsal hippocampal lesions do react to new stimuli but not to spatial changes of known stimuli. Behav. Neural. Biol. 54:1990;172-183.
54. Yeh T.S., Wang C.R., Jeng G.W., Lee G.L., Chen M.Y.et al. The study of anticardiolipin antibodies and interleukin-6 in cerebrospinal fluid and blood of Chinese patients with systemic lupus erythematosus and central nervous system involvement. Autoimm. 18:1994;169-175.
55. Zvaifler N.J., Bluestein H.G. The pathogenesis of central nervous system manifestations of systemic lupus erythematosus. Arth. Rheum. 25:1982;862-866.
56. Zalcman S., Nance D.M., Greenberg A.H. Behavioral activating effects of interleukin (IL)-2 and IL-6. Soc. Neurosci. Abstr. 21:1995;884.
57. Zalcman S., Green-Johnson J.M., Murray L., Nance D.M., Dyck D.G., Anisman H., Greenberg A.H. Cytokine-specific central monoamine alterations induced by interleukin (IL)-2, IL-2 and IL-6. Brain Res. 643:1994;40-49.